KCT0005210已完成未知
Randomized Phase II Study of Palliative Chemotherapy plus Controlled Diet with/ or without Metformin in Patients with Advanced Solid Tumors
ational Cancer Center0 个研究点目标入组 188 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 188
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1.cytologically or histologically confirmed diagnosis of nonsmall cell lung cancer or small cell lung cancer
- •2.18 years of age or older
- •3.a performance status (PS) of = 2 on the Eastern Cooperative Oncology Group (ECOG) scale
- •4.at least one measurable or evaluable tumour lesion
- •5.adequate organ function and normal hematologic function
排除标准
- •1.previous systemic chemotherapy (ex: monoclonal antibody)
- •2.previous radiation therapy without no progression on target lesions within radiation portal.
- •3.Active interstitial lung disease (radiation change without symptom would be permitted)
- •4.Invasive malignant tumor history within 5 years except skin basal carcinoma. Cervical in situ carcinoma, and thyroid cancer
- •5.Brain metastasis or leptomeningeal carcinomatosis requiring steroid with neurologic abnormality
- •6.History of metformin administration within 3 months
- •7.Known EGFR mutations
研究者
相似试验
进行中（未招募）
不适用
Randomized fase II study using chemiotherapy with metformine in patients affected by pancreas metastatic cancer. - NDpancreas metastatic tumorMedDRA version: 9.1Level: HLTClassification code 10033632EUCTR2010-020979-23-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
进行中（未招募）
不适用
A Randomized Phase II Study of two chemotherapy regimens, Pemetrexed-Carboplatin, and Gemcitabine-Vinorelbine, in Anthracycline and Taxane Pretreated Advanced Breast Cancer Patients - NDWomen with histologic or cytologic diagnosis of advanced breast cancer, who have received one prior chemotherapy containing anthracyclines as neo adjuvant or palliative 1st-line treatment and one prior chemotherapy containing taxanes as neo adjuvant or palliative 1st-line treatment.MedDRA version: 8.1Level: LLTClassification code 10055113Term: Breast cancer metastaticEUCTR2006-000441-19-ITELI LILLY160
已完成
2 期
A randomized phase II trial of adjuvant Chemotherapy with Gemcitabine alone, S-1 alone, versus gemcitabine and S-1 in patients with resected pancreatic cancerIncasive ductal carcinoma of pancreas with macroscopic complete resectionJPRN-UMIN000002000Chiba study group of adjuvant chemotherapy for pancreatic cancer96
招募中
2 期
A randomized phase II study of systemic chemotherapy with and without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis (JCOG1301C:Trigger Study)HER2 positive gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis.JPRN-UMIN000016920Japan Clinical Oncology Group (JCOG)130
进行中（未招募）
不适用
Randomized phase II trial of first line chemoterapy Docetaxel given in combination with Cisplatin for 6 cycles or Docetaxel given in combination with Cisplatin for 3 cycles followed by Docetaxel alone for 3 cycles in patients with advanced non-small-cell lung cancer. - NDPatients with advanced non-small-cell lung cancerMedDRA version: 9.1Level: LLTClassification code 10026532Term: Malignant neoplasm of thoraxEUCTR2007-002625-77-ITFONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO